ArticleESMO real world data and digital oncology2025

Reply to the Correspondence regarding "Sequencing the anti-EGFR-TKIs; route to the longest survival" by H.G. Güzel et al.

Y Uehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.